| Issue |
Section |
Title |
File |
| Vol 24, No 1 (2022) |
Review |
Acute decompensated heart failure. What has changed in the clinical guidelines in 2021? |
(Rus)
|
| Vol 24, No 1 (2022) |
Review |
Chronic heart failure – modification of treatment paradigm |
(Rus)
|
| Vol 24, No 1 (2022) |
Review |
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review |
(Rus)
|
| Vol 24, No 10 (2022) |
Articles |
Heart failure as a complication of myocardial infarction: rational therapy. Case report |
(Rus)
|
| Vol 25, No 1 (2023): Cardiovascular diseases |
Articles |
Exogenous ketone therapy for heart failure: A review |
(Rus)
|
| Vol 25, No 1 (2023): Cardiovascular diseases |
Articles |
A clinical case of hereditary transthyretin amyloidosis. Case report |
(Rus)
|
| Vol 25, No 4 (2023): Endocrinology |
Articles |
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction |
(Rus)
|
| Vol 25, No 10 (2023): Болезни сердца и сосудов |
Articles |
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region) |
(Rus)
|
| Vol 26, No 1 (2024): Cardiology and Nephrology |
Articles |
Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review |
(Rus)
|
| Vol 26, No 10 (2024): CARDIOLOGY AND NEPHROLOGY |
Articles |
SGLT-2 inhibitors in the management of acute decompensated heart failure |
(Rus)
|
| Vol 26, No 12 (2024): Коморбидность в клинике внутренних болезней |
Articles |
Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure |
(Rus)
|
| Vol 27, No 4 (2025): Эндокринология |
Articles |
Allopurinol in the complex therapy of acute decompensation of heart failure |
(Rus)
|
| Vol 27, No 5 (2025): GASTROENTEROLOGY |
Articles |
Possibilities of hyperuricemia correction in acute decompensation of heart failure |
(Rus)
|
